Valion Bio VBIO 深 沪
已收盘 08-21 16:00:00 美东时间
0.1226
+0.001
+0.41%
华盛通- 最 高0.132
- 今 开0.1185
- 成交量 390.07万股
- 最 低 0.1116
- 昨 收 0.1221
- 总市值 272.05万
- 52周最高 3.2077
- 市盈率 静 --
- 换手率 17.58%
- 52周最低 0.1116
- 委 比 0.00%
- 总股本 2218.97万
- 历史最高 11050.00
- 量 比 0.09
- 振 幅 16.71%
- 历史最低 0.1116
- 每 手 1
- 风险率 0.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Valion Bio To Carry Out Study At Sheba Medical Center To Mull Entolimod In 10 Cancer Participants
Valion Bio, Inc. (NASDAQ:VBIO) today announced a major clinical development milestone with the finalization of an clinical trial protocol at Sheba Medical Center, one of the world's leading hospitals, to evaluate Entolimod in cancer patients receiving high doses of irradiation for a rare form of can...
07-21 01:35
Valion Bio Q1 2026 Earnings Call: Complete Transcript
On Thursday, Valion Bio (NASDAQ:VBIO) discussed first-quarter financial results...
05-15 05:20
Valion Bio's Velocity Bioworks Enters Into Exclusive Commercial Development And License Agreement With LarmorBio For BioScan-NMR Platform
First Commercial Installation Targeted for July 2026 in San Antonio; Strategic Reference Site Positions Velocity Bioworks at the Forefront of Next-Generation NMR-Based DiagnosticsSAN ANTONIO, May 14, 2026 /PRNewswire/ --
05-15 04:34
Valion Bio Q1 EPS $(2.23) Up From $(2.52) YoY
Valion Bio (NASDAQ:VBIO) reported quarterly losses of $(2.23) per share. This is a 11.51 percent increase over losses of $(2.52) per share from the same period last year.
05-15 04:08
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Valion Bio Appoints Melinda Lackey as General Counsel
Seasoned Biopharmaceutical Attorney with Deep IP, Clinical-Stage, and Nasdaq Public Company Experience Joins Leadership Team SAN ANTONIO, May 4, 2026 /PRNewswire/ -- Valion Bio, Inc. (former...
05-05 04:05
VALION BIO BRIEFS PENTAGON LEADERSHIP ON ENTOLIMOD™ FOR ACUTE RADIATION SYNDROME
Company Presented Entolimod™ from its TLR5 Platform to the Deputy Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs SAN ANTONIO, April 28, 2026 /PRNewswir...
04-28 20:01
Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening
Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.
04-24 16:17
